Graypoint LLC’s Evolus EOLS Stock Holding History

Graypoint LLC’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-11,110	Closed	-$46K	–	158
2020 Q1	$46K	Buy	+11,110	New	+$94.2K	0.01%	150

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Graypoint LLC's EOLS Position: Q2 2020 in Review

Graypoint LLC sold out of Evolus (EOLS) in Q2 2020, closing a stake of 11,110 shares — an estimated $46K sold.

Graypoint LLC first reported a position in EOLS in Q1 2020 and held it in 1 quarter. The position peaked at $46K in Q1 2020. 90 funds tracked by Wall St. Rank hold EOLS as of Q2 2020.

Graypoint LLC reported no remaining Evolus position as of Q2 2020 after selling out during the quarter.
Graypoint LLC sold 11,110 Evolus shares in Q2 2020, an estimated $46K.
Graypoint LLC first reported a position in Evolus in Q1 2020 and held it in 1 quarter.
Graypoint LLC's Evolus position peaked at $46K in Q1 2020.
90 funds tracked by Wall St. Rank held Evolus as of Q2 2020.

Based on Graypoint LLC's 13F filing for Q2 2020, filed 30 Jul 2020.